Diseases, Conditions, Syndromes

FDA approves Leqselvi for severe alopecia

The U.S. Food and Drug Administration has approved Leqselvi (deuruxolitinib) tablets for the treatment of adults with severe alopecia areata.

Cardiology

Study finds lasting, reliable performance for wireless pacemaker

A dual-chamber wireless pacemaker provides reliable performance over three months, bolstering evidence for this new pacemaker option, according to results from a multi-center, international clinical trial co-led by a Weill ...

Medications

European medicines watchdog rejects new Alzheimer's drug

Europe's medicines watchdog on Friday rejected a marketing request for a new Alzheimer's disease treatment, saying the risks of the medicine's side effects, including potential brain bleeding, outweighed the benefits.

page 3 from 5